Beth Israel Deaconess Hospital- Plymouth is a hospital located in Plymouth, Massachusetts. Founded in 1901, it is today the largest hospital in the Southern region of the South Shore. BID-Plymouth is an acute care, 164-bed, not-for-profit community hospital serving 12 towns in Plymouth and Barnstable counties.

During the past decade, Beth Israel Deaconess Hospital-Plymouth conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beth Israel Deaconess Hospital-Plymouth" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beth Israel Deaconess Hospital-Plymouth" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Beth Israel Deaconess Hospital-Plymouth" are "Breast Cancer" (2 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "Invasive Breast Carcinoma" (2 trials), "Prostate Cancer" (2 trials) and "Chronic Lymphocytic Leukemia (CLL)" (1 trials). Many other conditions were trialed in "Beth Israel Deaconess Hospital-Plymouth" in a lesser frequency.

Most popular intervention types in "Beth Israel Deaconess Hospital-Plymouth" are "Drug" (10 trials), "Other" (7 trials), "Radiation" (5 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Quality-of-Life Assessment" (3 trials), "Cisplatin" (2 trials) and "Laboratory Biomarker Analysis" (2 trials). Other intervention names were less common.

The vast majority of trials in "Beth Israel Deaconess Hospital-Plymouth" are 10 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Beth Israel Deaconess Hospital-Plymouth". undefined are not yet recruiting, 3 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Beth Israel Deaconess Hospital-Plymouth, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Beth Israel Deaconess Hospital-Plymouth, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Beth Israel Deaconess Hospital-Plymouth has several departments that took part in Clinical trials: "Jordan Hospital Club Cancer Center" - 11 trials